ONRELTEA
Google image searchProduct monograph
Active ingredient
brimonidine (brimonidine tartrate), 0.33 %/W/W
DIN: 02421208
Dosage form(s): GEL
Route(s) of administration: TOPICAL
Schedule: Prescription
Company: GALDERMA CANADA INC
Date: 24-MAR-2014
ATC:
- D11 — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
- D11A — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD)
- D11AX — Other dermatologicals (ATC, ATC/DDD)
- D11AX21 — BRIMONIDINE (ATC/DDD)
Reference brand drug: Onreltea
Pharmaceutical standard: MFR
